CITADEL ADVISORS LLC 13D/13G Filings for IBERE PHARMACEUTICALS UNIT 1 C (IBERU)

CITADEL ADVISORS LLC 13D and 13G filings for IBERE PHARMACEUTICALS UNIT 1 C:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-03-12
4:02 pm
Purchase
2021-03-02 13G IBERE PHARMACEUTICALS UNIT 1 C
IBERU
CITADEL ADVISORS LLC 776,710
5.600%
776,710increase
(New Position)
Filing